TKL Research, a full-service clinical research organisation (CRO) based in Rochelle Park, NJ in the US, says Jeffrey Bagshaw has joined the company as Vice President of Global Business Development for the Clinical Trials Division. Bagshaw will be responsible for leading strategic corporate and business development efforts internationally.
Previously, Bagshaw was Chief Operating Officer at Inclinix, where he was responsible for leading global operations, strategic partnership development and clinical research services. While at the company, he held various leadership roles in medical marketing and compliance, medical support services and business development.
Bagshaw has more than 25 years of experience in the pharmaceutical, biotechnology, medical device and applied genomic industries, and he has been responsible for the clinical development and marketing of products across numerous therapeutic areas. His experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences.
